SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-13-000054
Filing Date
2013-01-17
Accepted
2013-01-17 11:18:01
Documents
4
Period of Report
2013-01-17

Document Format Files

Seq Description Document Type Size
1 6-K v332140_6k.htm 6-K 11660
2 EXHIBIT 99.1 v332140_ex99-1.htm EX-99.1 357567
3 EXHIBIT 99.2 v332140_ex99-2.htm EX-99.2 134382
4 EXHIBIT 99.3 v332140_ex99-3.htm EX-99.3 158212
  Complete submission text file 0001279569-13-000054.txt   663042
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 13533990
SIC: 2836 Biological Products, (No Diagnostic Substances)